CompoSecure, Inc. (Nasdaq: CMPO), a leader in metal payment cards,
security, and authentication solutions, today announced its
operating results for the second quarter ended June 30, 2024.
“I am pleased to report another record quarter
of Net Sales and Adjusted EBITDA, driven by continued growth in our
domestic business and strong international demand from the launch
of new programs,” said Jon Wilk, President and CEO of CompoSecure.
We continue to support our customer’s ability to offer highly
attractive premium card programs such as the limited edition Amex
White Gold Card and the first Wells Fargo and Expedia co-branded
metal card, as well as driving growth with innovative products
through our Echo Mirror Card and LED card.
“I am also excited to announce an expansion of
our strategic partnership with Fiserv to include the marketing and
reselling of Arculus Authenticate. Building on our already
successful metal payment card collaboration, this partnership will
enhance the ability to bring FIDO 2 secure authentication
capabilities to Fiserv’s extensive customer base of financial
institutions and fintechs.”
As just announced in a separate press release,
the David Cote Family is investing $372 million through Resolute
and Dave Cote will become the executive chairman of the board of
directors of CompoSecure upon closing of the transaction. Resolute
will become the majority shareholder of the Company and will focus
on deploying operational and M&A best practices to drive
long-term value creation for all shareholders. Importantly, the
transaction will remove the dual-share structure, delivering higher
retained annual cash flow and better alignment of all shareholders
with the elimination of the tax distributions related to the Class
B units.
Mr. Wilk continued, “I am thrilled to have David
Cote serve as Executive Chairman of the Board of Directors. David’s
career and track record is unparalleled, setting the standard for
how organizations can simultaneously drive both short and long-term
performance to realize their full potential. We believe his
experience steering global public companies, such as Honeywell and
Vertiv, will be invaluable to CompoSecure as we enter a new phase
of growth and value creation for shareholders, employees, and
customers.”
Wilk added, “Today, we have also amended our
credit facility with lower rates, an upsized revolving line of
credit, a longer term and more flexible covenants. This reflects
the confidence our lenders have in our business and provides
capacity for continued growth and to retire our exchangeable notes
maturing in December 2026.”
Financial Highlights
(Q2 2024
vs. Q2
2023)
- Net Sales: Net
Sales increased 10% to $108.6 million compared to $98.5 million.
The increase was primarily driven by continued domestic growth and
improved international demand.
- Gross Profit:
Gross Profit was $56.1 million or 52% of Net Sales, compared to
$53.9 million or 55%. The decrease in gross margin was primarily
due to product mix, as well as inflationary pressure on wages.
- Net Income/EPS:
Net Income increased 3% to $33.6 million compared to $32.7 million.
Net Income per share attributable to Class A common shareholders
was $0.44 (Basic) and $0.32 (Diluted), compared to $0.31 (Basic)
and $0.29 (Diluted) in the year-ago period.
- Adjusted Net
Income/Adjusted EPS: Adjusted Net Income (a non-GAAP
measure) increased 10% to $25.2 million compared to $22.9 million
in the year-ago period. Adjusted EPS (a non-GAAP measure), which
includes both Class A and Class B shares, was $0.31 (Basic) and
$0.27 (Diluted) compared to $0.29 (Basic) and $0.25 (Diluted) in
the year-ago period (see reconciliation of non-GAAP measures shown
in table below).
- Adjusted EBITDA:
Adjusted EBITDA (a non-GAAP measure) increased 8% to $40.0 million
compared to $36.9 million, with the increase driven by net sales
growth.
Liquidity and Capital
Structure
Balance Sheet: At June 30,
2024, CompoSecure had $35.4 million of cash and cash equivalents
and $330.9 million of total debt, which included $200.9 million of
term loan and $130 million of exchangeable notes. This compares to
cash and cash equivalents of $41.2 million and total debt of $340.3
million at December 31, 2023, and cash and cash equivalents of
$22.6 million and total debt of $358.1 million at
June 30, 2023. CompoSecure’s secured debt leverage ratio was
1.29x at June 30, 2024 compared to 1.39x at December 31, 2023
and 1.60x at June 30, 2023.
Shares Outstanding: At June 30,
2024, CompoSecure had 81.7 million shares outstanding which
included 29.8 million Class A shares and 51.9 million Class B
shares. This includes the effect of the May 2024 underwritten
secondary offering of approximately 8.1 million shares of Class A
common stock, which were converted from shares of Class B common
stock (for more information on shares outstanding, both Basic and
Diluted, please refer to CompoSecure’s SEC filings and the earnings
presentation).
Operational Highlights
- Expanded partnership with Fiserv to
market and resell Arculus Authenticate capabilities to Fiserv’s
customer base
- Customer card programs launched include Wells Fargo Expedia
Onekey Card, the Amex White Gold Card, Turkish Airlines, and Atlas,
a leading fintech.
- Arculus highlights:
- Remain on track for Arculus total net investment to be lower
than 2023, with the expectation of turning positive for fiscal
2025
- Showcased Arculus innovation around
Web3 payment capabilities using digital assets for everyday
purchases at point of sale
- CompoSecure recognition:
- Won three 2024 International Card
Manufactures Awards Elan Award: Best Metal Cards, Best
Environmentally-Friendly Cards, and Best Secure Payment Cards
- Jon Wilk, CEO, Visionary CEO Award
from the Banking Tech Awards USA
- Steve Feder, General Counsel, NJBIZ
Leaders in Law Awards
- Released inaugural ESG Report
2024 Financial OutlookThe
Company has narrowed its previously issued fiscal 2024 guidance and
now expects Net Sales to range between $418-$428 million
(previously $408-428 million) and Adjusted EBITDA to range between
$150-$157 million (previously $147-$157 million).
Conference CallCompoSecure will
host a conference call and live audio webcast today at 5:00 p.m.
Eastern Time to discuss its financial and operational results,
followed by a question-and-answer period.
Date: Wednesday, August 7, 2024Time: 5:00 p.m.
Eastern TimeDial-in registration link Live webcast registration
link
If you have any difficulty registering or
connecting with the conference call, please contact Elevate IR at
(720) 330-2829.
A live webcast and replay of the conference call
will be available on the investor relations section of
CompoSecure’s website at
https://ir.composecure.com/news-events/events.
About CompoSecureFounded in
2000, CompoSecure (Nasdaq: CMPO) is a technology partner to market
leaders, fintech’s and consumers enabling trust for millions of
people around the globe. The company combines elegance, simplicity
and security to deliver exceptional experiences and peace of mind
in the physical and digital world. CompoSecure’s innovative payment
card technology and metal cards with Arculus security and
authentication capabilities deliver unique, premium branded
experiences, enable people to access and use their financial and
digital assets, and ensure trust at the point of a transaction. For
more information, please visit www.CompoSecure.com and
www.GetArculus.com.
Forward-Looking StatementsThis press release
contains forward-looking statements as defined by the Private
Securities Litigation Reform Act of 1995. These statements are
based on the beliefs and assumptions of management. Although
CompoSecure believes that its plans, intentions, and expectations
reflected in or suggested by these forward-looking statements are
reasonable, CompoSecure cannot assure you that it will achieve or
realize these plans, intentions, or expectations. Forward-looking
statements are inherently subject to risks, uncertainties, and
assumptions. Generally, statements that are not historical facts,
including statements concerning CompoSecure’s possible or assumed
future actions, business strategies, events, or results of
operations, are forward-looking statements. In some instances,
these statements may be preceded by, followed by or include the
words “believes,” “estimates,” “expects,” “projects,” “forecasts,”
“may,” “will,” “should,” “seeks,” “plans,” “scheduled,”
“anticipates” or “intends” or the negatives of these terms or
variations of them or similar terminology. Forward-looking
statements are not guarantees of performance. You should not put
undue reliance on these statements which speak only as of the date
hereof. You should understand that the following important factors,
among others, could affect CompoSecure’s future results and could
cause those results or other outcomes to differ materially from
those expressed or implied in CompoSecure’s forward-looking
statements: the completion of the transactions contemplated by
the proposed transactions with Resolute Partners; the ability of
CompoSecure to grow and manage growth profitably; maintain
relationships with customers; compete within its industry and
retain its key employees; the possibility that CompoSecure may be
adversely impacted by other global economic, business, competitive
and/or other factors; the outcome of any legal proceedings that may
be instituted against CompoSecure or others; future exchange and
interest rates; and other risks and uncertainties, including those
under “Risk Factors” in filings that have been made or
will be made with the Securities and Exchange Commission.
CompoSecure undertakes no obligations to update or revise publicly
any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by
law.
Use of Non-GAAP Financial
MeasuresThis press release may include certain non-GAAP
financial measures that are not prepared in accordance with
accounting principles generally accepted in the United States
(“GAAP”) and that may be different from non-GAAP financial measures
used by other companies. CompoSecure believes EBITDA, Adjusted
EBITDA, Adjusted Net Income, Adjusted EPS, and Free Cash Flow are
useful to investors in evaluating CompoSecure’s financial
performance. CompoSecure uses these measures internally to
establish forecasts, budgets and operational goals to manage and
monitor its business, as well as evaluate its underlying historical
performance and/or to measure incentive compensation, as we believe
that these non-GAAP financial measures depict the true performance
of the business by encompassing only relevant and controllable
events, enabling CompoSecure to evaluate and plan more effectively
for the future. Due to the forward-looking nature of the financial
guidance included above, specific quantification of the charges
excluded from the non-GAAP financial measures included in such
financial guidance, including with respect to depreciation,
amortization, interest, and taxes, that would be required to
reconcile the non GAAP financial measures included in such
financial guidance to GAAP measures are not available, so it is not
feasible to provide accurate forecasted non-GAAP reconciliations
without unreasonable effort. Consequently, no disclosure of
estimated comparable GAAP measures is included, and no
reconciliation of the forward-looking non-GAAP financial measures
is included. In addition, CompoSecure’s debt agreements contain
covenants that use a variation of these measures for purposes of
determining debt covenant compliance. CompoSecure believes that
investors should have access to the same set of tools that its
management uses in analyzing operating results. EBITDA, Adjusted
EBITDA, Adjusted Net Income, Adjusted EPS, and Free Cash Flow
should not be considered as measures of financial performance under
U.S. GAAP, and the items excluded from EBITDA, Adjusted EBITDA,
Adjusted Net Income, Adjusted EPS, and Free Cash Flow are
significant components in understanding and assessing CompoSecure’s
financial performance. Accordingly, these key business metrics have
limitations as an analytical tool. They should not be considered as
an alternative to net income or any other performance measures
derived in accordance with U.S. GAAP or as an alternative to cash
flows from operating activities as a measure of CompoSecure’s
liquidity and may be different from similarly titled non-GAAP
measures used by other companies. Please refer to the tables below
for the reconciliation of GAAP measures to these non-GAAP
measures.
Corporate ContactAnthony
PiniellaHead of Global Communications, CompoSecure(917)
208-7724apiniella@composecure.com
Investor Relations ContactSean
Mansouri, CFAElevate IR(720) 330-2829CMPO@elevate-ir.com
Consolidated Balance Sheet Data(in thousands) |
|
|
June 30,2024 |
|
December 31,2023 |
|
Unaudited |
|
|
ASSETS |
|
|
|
CURRENT ASSETS |
|
|
|
Cash and cash equivalents |
$ |
35,391 |
|
|
$ |
41,216 |
|
Accounts receivable, net |
|
39,648 |
|
|
|
40,488 |
|
Inventories |
|
57,514 |
|
|
|
52,540 |
|
Prepaid expenses and other current assets |
|
3,928 |
|
|
|
5,133 |
|
Total current assets |
|
136,481 |
|
|
|
139,377 |
|
|
|
|
|
Property and equipment,
net |
|
23,739 |
|
|
|
25,212 |
|
Right of use assets, net |
|
6,449 |
|
|
|
7,473 |
|
Deferred tax asset |
|
41,082 |
|
|
|
23,697 |
|
Derivative asset - interest
rate swap |
|
5,182 |
|
|
|
5,258 |
|
Deposits and other assets |
|
422 |
|
|
|
24 |
|
Total assets |
$ |
213,355 |
|
|
$ |
201,041 |
|
|
|
|
|
LIABILITIES AND
STOCKHOLDERS' DEFICIT |
|
|
|
CURRENT LIABILITIES |
|
|
|
Accounts payable |
|
9,431 |
|
|
|
5,193 |
|
Accrued expenses |
|
12,183 |
|
|
|
11,986 |
|
Commission payable |
|
5,010 |
|
|
|
4,429 |
|
Bonus payable |
|
5,473 |
|
|
|
5,616 |
|
Current portion of long-term debt |
|
13,437 |
|
|
|
10,313 |
|
Current portion of lease liabilities |
|
2,029 |
|
|
|
1,948 |
|
Current portion of tax receivable agreement liability |
|
1,425 |
|
|
|
1,425 |
|
Total current liabilities |
|
48,988 |
|
|
|
40,910 |
|
|
|
|
|
Long-term debt, net of
deferred finance costs |
|
186,244 |
|
|
|
198,331 |
|
Convertible notes |
|
128,088 |
|
|
|
127,832 |
|
Derivative liability -
convertible notes redemption make-whole provision |
|
544 |
|
|
|
425 |
|
Warrant liability |
|
10,087 |
|
|
|
8,294 |
|
Lease liabilities,
operating |
|
5,077 |
|
|
|
6,220 |
|
Tax receivable agreement
liability |
|
43,060 |
|
|
|
23,949 |
|
Earnout consideration
liability |
|
383 |
|
|
|
853 |
|
Total liabilities |
|
422,471 |
|
|
|
406,814 |
|
|
|
|
|
Commitments and contingencies
(Note 13) |
|
|
|
|
|
|
|
Redeemable non-controlling
interest |
|
516,489 |
|
|
|
596,587 |
|
|
|
|
|
Preferred stock, $0.0001 par
value; 10,000,000 shares authorized, no shares issued and
outstanding |
|
— |
|
|
|
— |
|
Class
A common stock, $0.0001 par value; 250,000,000 shares authorized,
29,847,338 and 19,415,123 shares issued and outstanding as of
June 30, 2024 and December 31, 2023, respectively. |
|
3 |
|
|
|
2 |
|
Class
B common stock, $0.0001 par value; 75,000,000 shares authorized,
51,908,422 and 59,958,422 shares issued and outstanding as of
June 30, 2024 and December 31, 2023, respectively. |
|
5 |
|
|
|
6 |
|
Additional paid-in
capital |
|
36,258 |
|
|
|
39,466 |
|
Accumulated other
comprehensive income |
|
4,848 |
|
|
|
4,991 |
|
Accumulated deficit |
|
(766,719 |
) |
|
|
(846,825 |
) |
Total stockholders'
deficit |
|
(725,605 |
) |
|
|
(802,360 |
) |
TOTAL LIABILITIES AND
STOCKHOLDERS' DEFICIT |
$ |
213,355 |
|
|
$ |
201,041 |
|
|
|
|
|
|
|
|
|
Consolidated Statements of Operations(in thousands, except per
share amounts)(unaudited) |
|
|
Three months ended June 30, |
|
Six months ended June 30, |
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
Net sales |
$ |
108,567 |
|
|
$ |
98,527 |
|
|
$ |
212,577 |
|
|
$ |
193,843 |
|
Operating expenses: |
|
|
|
|
|
|
|
Cost of sales |
|
52,495 |
|
|
|
44,590 |
|
|
|
101,292 |
|
|
|
86,552 |
|
Selling, general and administrative expenses |
|
24,279 |
|
|
|
23,588 |
|
|
|
48,357 |
|
|
|
47,532 |
|
Total operating expenses |
|
76,774 |
|
|
|
68,178 |
|
|
|
149,649 |
|
|
|
134,084 |
|
|
|
|
|
|
|
|
|
Income from operations |
|
31,793 |
|
|
|
30,349 |
|
|
|
62,928 |
|
|
|
59,759 |
|
|
|
|
|
|
|
|
|
Total other income (expense),
net |
|
2,062 |
|
|
|
3,331 |
|
|
|
(12,836 |
) |
|
|
(16,605 |
) |
Income before income
taxes |
|
33,855 |
|
|
|
33,680 |
|
|
|
50,092 |
|
|
|
43,154 |
|
Income tax (expense)
benefit |
|
(258 |
) |
|
|
(970 |
) |
|
|
578 |
|
|
|
293 |
|
Net income |
$ |
33,597 |
|
|
$ |
32,710 |
|
|
$ |
50,670 |
|
|
$ |
43,447 |
|
|
|
|
|
|
|
|
|
Net income attributable to redeemable non-controlling
interests |
$ |
22,498 |
|
|
$ |
26,973 |
|
|
$ |
33,629 |
|
|
$ |
35,347 |
|
Net income attributable to CompoSecure, Inc. |
$ |
11,099 |
|
|
$ |
5,737 |
|
|
$ |
17,041 |
|
|
$ |
8,100 |
|
|
|
|
|
|
|
|
|
Net income per share
attributable to Class A common stockholders - basic |
$ |
0.44 |
|
|
$ |
0.31 |
|
|
$ |
0.74 |
|
|
$ |
0.45 |
|
Net income per share
attributable to Class A common stockholders - diluted |
$ |
0.32 |
|
|
$ |
0.29 |
|
|
$ |
0.49 |
|
|
$ |
0.41 |
|
|
|
|
|
|
|
|
|
Weighted average shares used
to compute net income per share attributable to Class A common
stockholders - basic (in thousands) |
|
25,438 |
|
|
|
18,537 |
|
|
|
23,003 |
|
|
|
18,087 |
|
Weighted average shares used
to compute net income per share attributable to Class A common
stockholders - diluted (in thousands) |
|
96,641 |
|
|
|
35,528 |
|
|
|
96,438 |
|
|
|
35,155 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated Statements of Cash Flows(in thousands)(unaudited) |
|
|
Six months ended June 30, |
|
|
2024 |
|
|
|
2023 |
|
|
|
|
|
Cash flows from operating
activities: |
|
|
|
Net income |
$ |
50,670 |
|
|
$ |
43,447 |
|
Adjustments to reconcile net income to net cash provided by
operating activities |
|
|
|
Depreciation and amortization |
|
4,601 |
|
|
|
4,171 |
|
Stock-based compensation expense |
|
9,635 |
|
|
|
8,415 |
|
Amortization of deferred finance costs |
|
669 |
|
|
|
700 |
|
Change in fair value of earnout consideration liability |
|
(470 |
) |
|
|
(4,221 |
) |
Revaluation of warrant liability |
|
1,793 |
|
|
|
7,968 |
|
Change in fair value of derivative liability |
|
119 |
|
|
|
513 |
|
Deferred tax (benefit) |
|
(2,922 |
) |
|
|
(1,770 |
) |
Changes in assets and liabilities |
|
|
|
Accounts receivable |
|
840 |
|
|
|
738 |
|
Inventories |
|
(4,974 |
) |
|
|
(6,515 |
) |
Prepaid expenses and other assets |
|
1,205 |
|
|
|
(272 |
) |
Accounts payable |
|
4,238 |
|
|
|
(492 |
) |
Accrued expenses |
|
197 |
|
|
|
612 |
|
Other liabilities |
|
399 |
|
|
|
(313 |
) |
Net cash provided by operating
activities |
|
66,000 |
|
|
|
52,981 |
|
|
|
|
|
Cash flows from investing
activities: |
|
|
|
Purchase of property and equipment |
|
(3,129 |
) |
|
|
(5,697 |
) |
Capitalized software expenditures |
|
(398 |
) |
|
|
— |
|
Net cash used in investing
activities |
|
(3,527 |
) |
|
|
(5,697 |
) |
|
|
|
|
Cash flows from financing
activities: |
|
|
|
Proceeds from employee stock purchase plan and exercises of equity
awards |
|
221 |
|
|
|
389 |
|
Payments for taxes related to net share settlement of equity
awards |
|
(8,482 |
) |
|
|
(2,483 |
) |
Payment of tax receivable agreement liability |
|
— |
|
|
|
(2,193 |
) |
Payment of term loan |
|
(9,375 |
) |
|
|
(5,017 |
) |
Tax distributions to non-controlling members |
|
(26,167 |
) |
|
|
(29,008 |
) |
Special distribution to non-controlling members |
|
(15,573 |
) |
|
|
— |
|
Dividend to Class A shareholders |
|
(8,922 |
) |
|
|
— |
|
Net cash used in financing
activities |
|
(68,298 |
) |
|
|
(38,312 |
) |
|
|
|
|
Net (decrease) increase in
cash and cash equivalents |
|
(5,825 |
) |
|
|
8,972 |
|
|
|
|
|
Cash and cash equivalents,
beginning of period |
|
41,216 |
|
|
|
13,642 |
|
|
|
|
|
Cash and cash equivalents, end
of period |
$ |
35,391 |
|
|
$ |
22,614 |
|
|
|
|
|
Supplementary disclosure of
cash flow information: |
|
|
|
Cash paid for interest expense |
$ |
12,890 |
|
|
$ |
13,626 |
|
Supplemental disclosure of
non-cash financing activities: |
|
|
|
Derivative asset - interest rate swap |
$ |
(143 |
) |
|
$ |
(373 |
) |
|
|
|
|
|
|
|
|
Non-GAAP Adjusted EBITDA Reconciliation(in
thousands)(unaudited) |
|
|
Three months ended June 30, |
|
Six months ended June 30, |
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
(in thousands) |
Net income |
$ |
33,597 |
|
|
$ |
32,710 |
|
|
$ |
50,670 |
|
|
$ |
43,447 |
|
Add: |
|
|
|
|
|
|
|
Depreciation and
amortization |
|
2,380 |
|
|
|
2,131 |
|
|
|
4,601 |
|
|
|
4,171 |
|
Interest expense, net (1) |
|
5,648 |
|
|
|
5,849 |
|
|
|
11,394 |
|
|
|
12,345 |
|
Income tax expense
(benefit) |
|
258 |
|
|
|
970 |
|
|
|
(578 |
) |
|
|
(293 |
) |
EBITDA |
$ |
41,883 |
|
|
$ |
41,660 |
|
|
$ |
66,087 |
|
|
$ |
59,670 |
|
Stock-based compensation
expense |
|
5,238 |
|
|
|
4,393 |
|
|
|
9,635 |
|
|
|
8,415 |
|
Mark-to-market adjustments,
net (2) |
|
(7,710 |
) |
|
|
(9,180 |
) |
|
|
1,442 |
|
|
|
4,260 |
|
Secondary offering transaction
costs |
|
586 |
|
|
|
— |
|
|
|
586 |
|
|
|
— |
|
Adjusted EBITDA |
$ |
39,997 |
|
|
$ |
36,873 |
|
|
$ |
77,750 |
|
|
$ |
72,345 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Includes amortization of deferred financing cost for
the three and six months ended June 30, 2024 and 2023,
respectively.(2) Includes the changes in fair value of warrant
liability, derivative liabilities and earnout consideration
liability for the three and six months ended June 30, 2024 and
2023, respectively.
Non-GAAP Adjusted EPS Reconciliation(in thousands)(unaudited) |
|
|
Three months ended June 30, |
|
Six months ended June 30, |
|
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|
(in thousands) except per share amounts |
Basic and Diluted: |
|
|
|
|
|
|
|
Net Income |
$ |
33,597 |
|
|
$ |
32,710 |
|
|
$ |
50,670 |
|
|
$ |
43,447 |
|
Add (less): provision
(benefit) for income taxes |
|
258 |
|
|
|
970 |
|
|
|
(578 |
) |
|
|
(293 |
) |
Income before income
taxes |
|
33,855 |
|
|
|
33,680 |
|
|
|
50,092 |
|
|
|
43,154 |
|
Income tax expense (1) |
|
(6,982 |
) |
|
|
(6,190 |
) |
|
|
(13,387 |
) |
|
|
(11,771 |
) |
Adjusted net income before
adjustments |
|
26,873 |
|
|
|
27,490 |
|
|
|
36,705 |
|
|
|
31,383 |
|
(Less) add: mark-to-market
adjustments (2) |
|
(7,532 |
) |
|
|
(8,985 |
) |
|
|
1,323 |
|
|
|
3,747 |
|
Add: Secondary offering
transaction costs |
$ |
586 |
|
|
|
— |
|
|
|
586 |
|
|
|
— |
|
Add: stock-based
compensation |
|
5,238 |
|
|
|
4,393 |
|
|
|
9,635 |
|
|
|
8,415 |
|
Adjusted net income |
$ |
25,165 |
|
|
$ |
22,898 |
|
|
$ |
48,249 |
|
|
$ |
43,545 |
|
Common shares outstanding used
in computing net income per share, basic: |
|
|
|
|
|
|
|
Class A and Class B common
shares (3) |
|
81,151 |
|
|
|
78,496 |
|
|
|
80,838 |
|
|
|
78,046 |
|
Common shares outstanding used
in computing net income per share, diluted: |
|
|
|
|
|
|
|
Warrants (Public and Private)
(4) |
|
8,094 |
|
|
|
8,094 |
|
|
|
8,094 |
|
|
|
8,094 |
|
Equity awards |
|
2,490 |
|
|
|
3,991 |
|
|
|
2,600 |
|
|
|
4,068 |
|
Total Shares outstanding used
in computing net income per share - diluted |
|
91,735 |
|
|
|
90,581 |
|
|
|
91,532 |
|
|
|
90,208 |
|
|
|
|
|
|
|
|
|
Adjusted net income per share
- basic |
$ |
0.31 |
|
|
$ |
0.29 |
|
|
$ |
0.60 |
|
|
$ |
0.56 |
|
Adjusted net income per share
- diluted |
$ |
0.27 |
|
|
$ |
0.25 |
|
|
$ |
0.53 |
|
|
$ |
0.48 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1) Calculated using the Company's blended tax rate.2) Includes
the changes in fair value of warrant liability and earnout
consideration liability.3) Assumes both Class A shares and Class B
shares participate in earnings and are outstanding at the end of
the period. 4) Assumes treasury stock method, valuation at assumed
fair market value of $18.00.5) The Company did not include the
effect of Exchangeable Notes in its total shares outstanding used
in diluted adjusted net income per share.
CompoSecure (NASDAQ:CMPO)
Historical Stock Chart
From Dec 2024 to Jan 2025
CompoSecure (NASDAQ:CMPO)
Historical Stock Chart
From Jan 2024 to Jan 2025